Monogram Technologies

What Monogram Technologies does

Monogram Technologies was an Austin, Texas-based medical technology company developing an AI-powered orthopedic surgical robotics platform centered on the mBôs TKA System. The mBôs platform is a CT-based, semi-autonomous AI-navigated robotic arm with 7 degrees of freedom, foot actuation, precise cutting capabilities, and continuous patient and system monitoring, designed for total knee arthroplasty. The system integrates with personalized 3D-printed joint implants tailored to each patient's anatomy and uses machine learning algorithms to automate implant positioning, alignment optimization, and case processing through more than 1,000,000 lines of proprietary code. An adjacent product, the mVision registration and tracking technology, is in development, and a fully autonomous version of the mBôs system entered clinical enrollment in July 2025.

The company's revenue model was structured around hardware sales of surgical robotic systems and customized 3D-printed implants to hospitals and surgical centers, sold via direct enterprise field sales targeting orthopedic surgeons. Monogram received FDA 510(k) clearance for the mBôs TKA System in March 2025 and was acquired by Zimmer Biomet Holdings in October 2025 for approximately $177 million ($4.04 cash per share plus contingent value rights up to $12.37 per share tied to product development, regulatory, and revenue milestones through 2030). At acquisition, the company had received its first purchase order in 2023 but had not yet entered full commercialization, which is now expected under Zimmer Biomet's orthopedic distribution network by early 2027. Monogram had raised approximately $60.2 million across six funding rounds from 2017 through 2023, including a Series D round that coincided with its NASDAQ listing.

Name

Monogram Technologies

Legal name

Monogram Technologies Inc.

Website

https://monogramtechnologies.com

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

11–50 employees

Short description

Monogram Technologies developed the mBôs TKA surgical robotic system, combining AI-navigated CT-based robotics with 3D-printed personalized implants for orthopedic joint replacement. Following FDA 510(k) clearance in March 2025, the company was acquired by Zimmer Biomet in October 2025.

Ownership category

akta.pro rank

Product category

Surgical Robotics and Orthopedic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Healthcare & Assistive Robotics (HDAAAIAC), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)

Keywords

• Orthopedic surgical robotics
• Total knee arthroplasty
• 3D-printed implants
• Navigated surgical systems
• Personalized joint replacement

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Robotics Hardware and Software: Sale of mBôs surgical robotic systems to hospitals and surgical centers, including associated software licenses and case processing services
2. Personalized 3D-Printed Implants: Sale of customized 3D-printed implants matched to individual patient anatomy
3. Contingent Value Rights (CVRs): Non-tradeable CVRs worth up to $12.37 per share tied to product development, regulatory, and revenue milestones through 2030

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Monogram Technologies developed the mBôs TKA System, an FDA 510(k)-cleared CT-based semi-autonomous AI-navigated robotic platform for total knee arthroplasty, featuring a 7-degrees-of-freedom robotic arm with foot actuation and precise cutting capabilities. The company also manufactures personalized 3D-printed joint implants designed to match individual patient anatomy and reduce implant micro-mobility. Following its October 2025 acquisition by Zimmer Biomet, commercialization of the platform is expected by early 2027.

Product overview

Monogram Technologies offers a unified surgical robotics platform for orthopedic joint replacement centered on the mBôs™ TKA System. The platform integrates the mBôs robotic arm (featuring 7 degrees of freedom, foot actuation, and precise cutting capabilities) with personalized 3D-printed implants and AI-powered case processing software. The mVision technology is being developed as an add-on for enhanced registration and tracking. The Press-Fit CKS Total Knee provides an implant option for the system. Together, these products enable personalized, precise orthopedic surgery with the goal of achieving perfect implant fit and surgical outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• mBôs: AI-powered surgical robotic system for total knee arthroplasty (TKA) with semi-autonomous and fully autonomous capabilities
• mVision

Products and services

• mBôs TKA System FDA 510(k)-cleared CT-based semi-autonomous AI-navigated robotic system for total knee arthroplasty, featuring a 7-degrees-of-freedom robotic arm with foot actuation, precise cutting, continuous patient/system monitoring, and integration with personalized 3D-printed implants. Sold to hospitals and surgical centers performing joint replacement.
• 3D-Printed Customized Implants Customized 3D-printed joint implants tailored to match each patient's individual anatomy, designed to decrease micro-mobility and increase implant acceptance. Used in conjunction with the mBôs robotic system for knee and hip replacement procedures.
• Press-Fit CKS Total Knee

Quantifiable outcome

• Approximately 7x more stable than conventional hip replacement techniques (UCLA studies)
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature8 records

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Stryker (Mako Surgical System): Stryker's Mako system is the dominant orthopedic surgical robotics platform for total and partial knee arthroplasty, competing directly with Monogram's mBôs TKA platform for the same orthopedic surgeons and hospital customers in the same TKA robotics category.
• Smith+Nephew (CORI Surgical System): Smith+Nephew's CORI is a handheld and now platform-based orthopedic surgical robotics system for knee arthroplasty, directly competing with Monogram's mBôs in surgeon-targeted, CT-free/capability-based knee replacement robotics.
• Johnson & Johnson DePuy Synthes (Velys): DePuy Synthes' Velys robotic-assisted solution is a direct competitor in orthopedic surgical robotics for knee replacement, targeting the same hospital buyers and orthopedic surgeons as Monogram's mBôs TKA System.
• Think Surgical (TSolution One): Think Surgical builds active robotic systems specifically for total knee arthroplasty with an open implant platform, making it a focused direct competitor to Monogram in the TKA surgical robotics niche.
• Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a surgical robotics platform with orthopedic and spine applications; following Globus's merger with NuVasive it has expanded into robotic-assisted orthopedic procedures overlapping with Monogram's robotics approach.
• Renishaw (neuromate and neurosurgical robotics): Renishaw manufactures neurosurgical robotic systems (neuromate) and has expanded into orthopedic applications, sharing the precision-robotics-for-surgery category with Monogram and competing for hospital surgical robotics budgets.

Broad incumbents

• Medtronic (Mazor X Stealth Edition): Medtronic's Mazor X is a leading surgical robotics platform primarily for spine procedures but within a broad medical device portfolio that increasingly competes with Monogram for hospital capital budgets and OR integration slots.
• Intuitive Surgical (da Vinci): Intuitive Surgical is the global leader in surgical robotics (da Vinci systems) and represents the broader incumbent benchmark for surgeon adoption, training infrastructure, and recurring instrument/attachment revenue that Monogram's orthopedic robotics model aspires to replicate.

Emerging players

• restor3d (formerly Conformis): restor3d (which acquired Conformis) manufactures patient-specific 3D-printed knee and hip implants, directly overlapping Monogram's personalized implant business and offering an alternative path to personalized orthopedics without robotics.
• Corin (orthopedic implants and robotics): Corin is a privately held orthopedic implant and connected technology company with personalized hip/knee implants and digital surgical tools, making it a comparable peer in patient-specific orthopedic implants adjacent to Monogram's 3D-printed implant offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/zimmerbiomet
• YouTubeyoutube.com/@MonogramOrthopaedics
• Facebookfacebook.com/zimmerbiomet
• LinkedInlinkedin.com/company/zimmerbiomet
• Instagraminstagram.com/zimmerbiomet_zbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monogram Technologies